- B2C
- Early StageStartup in initial stages
Vitagene Funding
$5.5M
11 round
Vitagene is active in the following markets / industries: health care, machine learning, artificial intelligence, personal health, health and wellness and dietary supplements. The company has secured funding across 1 rounds, totaling in an amount of $5.5M. Their most recent funding was raised on February 17, 2016.
Funding Rounds
Investors of Vitagene
Kent is Co-Founder of Spectrum 28. He is passionate about working with teams on go-to market strategy and international expansion to Asia.
Viking Global Investors
Global investment firm managing capital across public equity, private equity, and credit strategies
Rounds
S
Founder of @DST
Rounds
S
Illumina Accelerator
Genomics Startup Accelerator in SF & Cambridge, UK